Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhibition of Drp1 Ameliorates Synaptic Depression, Aβ Deposition, and Cognitive Impairment in an Alzheimer's Disease Model
Seung Hyun Baek, So Jung Park, Jae In Jeong, et al.
Journal of Neuroscience (2017) Vol. 37, Iss. 20, pp. 5099-5110
Open Access | Times Cited: 214

Showing 1-25 of 214 citing articles:

Mitochondria dysfunction in the pathogenesis of Alzheimer’s disease: recent advances
Wenzhang Wang, Fanpeng Zhao, Xiaopin Ma, et al.
Molecular Neurodegeneration (2020) Vol. 15, Iss. 1
Open Access | Times Cited: 887
Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing
Stephen C. Cunnane, Eugenia Trushina, Cecilie Morland, et al.
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 9, pp. 609-633
Open Access | Times Cited: 683
Mitochondria at the neuronal presynapse in health and disease
Michael J. Devine, Josef T. Kittler
Nature reviews. Neuroscience (2018) Vol. 19, Iss. 2, pp. 63-80
Open Access | Times Cited: 512
Defective mitophagy in Alzheimer’s disease
Jangampalli Adi Pradeepkiran, P. Hemachandra Reddy
Ageing Research Reviews (2020) Vol. 64, pp. 101191-101191
Open Access | Times Cited: 255
The role of mitochondrial dysfunction in Alzheimer's disease pathogenesis
Theophania Ashleigh, Russell H. Swerdlow, M. Flint Beal
Alzheimer s & Dementia (2022) Vol. 19, Iss. 1, pp. 333-342
Closed Access | Times Cited: 240
Hippocampal phosphorylated tau induced cognitive decline, dendritic spine loss and mitochondrial abnormalities in a mouse model of Alzheimer’s disease
Ramesh Kandimalla, Maria Mańczak, Xiangling Yin, et al.
Human Molecular Genetics (2017) Vol. 27, Iss. 1, pp. 30-40
Open Access | Times Cited: 226
Lipopolysaccharide‐induced alteration of mitochondrial morphology induces a metabolic shift in microglia modulating the inflammatory response in vitro and in vivo
Syam Nair, Kristina S. Sobotka, Pooja Joshi, et al.
Glia (2019) Vol. 67, Iss. 6, pp. 1047-1061
Open Access | Times Cited: 211
Insulin Resistance and Oxidative Stress in the Brain: What’s New?
Mateusz Maciejczyk, Ewa Żebrowska, Adrian Chabowski
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 4, pp. 874-874
Open Access | Times Cited: 204
Mitochondrial dysfunction in the development and progression of neurodegenerative diseases
Joseph Johnson, Elizabeth Mercado‐Ayón, Yesica Mercado-Ayon, et al.
Archives of Biochemistry and Biophysics (2020) Vol. 702, pp. 108698-108698
Closed Access | Times Cited: 194
The energetic brain – A review from students to students
Melina Bordone, Mootaz M. Salman, Haley E. Titus, et al.
Journal of Neurochemistry (2019) Vol. 151, Iss. 2, pp. 139-165
Open Access | Times Cited: 169
Dynamics of Dynamin-Related Protein 1 in Alzheimer’s Disease and Other Neurodegenerative Diseases
Darryll Oliver, P. Hemachandra Reddy
Cells (2019) Vol. 8, Iss. 9, pp. 961-961
Open Access | Times Cited: 146
Impaired insulin signalling and allostatic load in Alzheimer disease
Fernanda G. De Felice, Rafaella A. Gonçalves, Sérgio T. Ferreira
Nature reviews. Neuroscience (2022) Vol. 23, Iss. 4, pp. 215-230
Closed Access | Times Cited: 126
Mitochondrial dysfunctions, oxidative stress and neuroinflammation as therapeutic targets for neurodegenerative diseases: An update on current advances and impediments
Muneeb U. Rehman, Nouroz Sehar, Nawab John Dar, et al.
Neuroscience & Biobehavioral Reviews (2022) Vol. 144, pp. 104961-104961
Closed Access | Times Cited: 83
Compilation of reported protein changes in the brain in Alzheimer’s disease
Manor Askenazi, Tomas Kavanagh, Geoffrey Pires, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 79
Physiology and pharmacology of amyloid precursor protein
Yoonsuk Cho, Han‐Gyu Bae, Eitan Okun, et al.
Pharmacology & Therapeutics (2022) Vol. 235, pp. 108122-108122
Closed Access | Times Cited: 78
Protective effects of luteolin against amyloid beta-induced oxidative stress and mitochondrial impairments through peroxisome proliferator-activated receptor γ-dependent mechanism in Alzheimer's disease
Zhijun He, Xiaoqian Li, Zi Wang, et al.
Redox Biology (2023) Vol. 66, pp. 102848-102848
Open Access | Times Cited: 68
Mitochondria in Alzheimer’s Disease Pathogenesis
Allison B. Reiss, Shelly Gulkarov, Benna Jacob, et al.
Life (2024) Vol. 14, Iss. 2, pp. 196-196
Open Access | Times Cited: 26
Mitochondrial disorders leading to Alzheimer’s disease—perspectives of diagnosis and treatment
Magdalena Pszczołowska, Kamil Walczak, Weronika Miśków, et al.
GeroScience (2024) Vol. 46, Iss. 3, pp. 2977-2988
Open Access | Times Cited: 17
Cholecystokinin (CCK): a neuromodulator with therapeutic potential in Alzheimer’s and Parkinson’s disease
Niklas Reich, Christian Hölscher
Frontiers in Neuroendocrinology (2024) Vol. 73, pp. 101122-101122
Open Access | Times Cited: 16
Mitochondrial dysfunction in Alzheimer's disease: Guiding the path to targeted therapies
Kyle C McGill Percy, Zhenguo Liu, Xin Qi
Neurotherapeutics (2025), pp. e00525-e00525
Open Access | Times Cited: 5
Naotaifang formula regulates Drp1-induced remodeling of mitochondrial dynamics following cerebral ischemia-reperfusion injury
Ruining She, Heyan Tian, Feiyue Sun, et al.
Free Radical Biology and Medicine (2025)
Closed Access | Times Cited: 3
Links Between Obesity-Induced Brain Insulin Resistance, Brain Mitochondrial Dysfunction, and Dementia
Jirapas Sripetchwandee, Nipon Chattipakorn, Siriporn C. Chattipakorn
Frontiers in Endocrinology (2018) Vol. 9
Open Access | Times Cited: 157
Mitochondrial division inhibitor 1 reduces dynamin-related protein 1 and mitochondrial fission activity
Maria Mańczak, Ramesh Kandimalla, Xiangling Yin, et al.
Human Molecular Genetics (2018) Vol. 28, Iss. 2, pp. 177-199
Open Access | Times Cited: 145
Oligodendroglial glycolytic stress triggers inflammasome activation and neuropathology in Alzheimer’s disease
Xinwen Zhang, Rihua Wang, Di Hu, et al.
Science Advances (2020) Vol. 6, Iss. 49
Open Access | Times Cited: 137
Drp1/Fis1 interaction mediates mitochondrial dysfunction, bioenergetic failure and cognitive decline in Alzheimer's disease
Amit U. Joshi, Nay L. Saw, Mehrdad Shamloo, et al.
Oncotarget (2017) Vol. 9, Iss. 5, pp. 6128-6143
Open Access | Times Cited: 121
Page 1 - Next Page

Scroll to top